Context-dependent accuracy of the cobas plasma separation card for HCV RNA viral load measurement

J Viral Hepat. 2024 Mar;31(3):156-160. doi: 10.1111/jvh.13910. Epub 2024 Jan 2.

Abstract

Collection and preservation of plasma are challenging in remote or under-resourced settings. The cobas® Plasma Separation Card (PSC) is an alternative specimen type for blood-borne pathogen nucleic acid quantitation. We assessed PSC as a specimen type for HCV RNA quantitation in Pakistan. Plasma from venous blood and PSC from finger prick blood were prepared at two sites: Site 1 (in Lahore, n = 199) consisted of laboratory-based outpatient clinics. Specimens were prepared in the same facility and stored frozen. Site 2 was a catchment area within a resource-limited, semi-urban locality of Islamabad with limited access to healthcare services (n = 151). Community public health outreach staff collected blood and prepared the PSC in the participants' homes. Specimens were transported to the central hepatitis laboratory in Lahore to be stored frozen until tested. HCV RNA testing was performed using the cobas HCV RNA test in a central laboratory. Concordance with respect to RNA detectability was high at Site 1 (97.4%), but lower at Site 2 (82.4%). At Site 1, HCV viral load in plasma and PSC were well correlated across the linear range with a 0.21 log10 IU/mL mean bias toward higher concentrations in PSC. At Site 2, HCV viral load in plasma and PSC were poorly correlated. There was a 0.11 log10 IU/mL mean bias toward higher concentrations in PSC. PSC performance can be excellent in underserved settings where refrigerated transport of traditional specimens is difficult. In very challenging field settings, extra support must be provided to ensure correct specimen collection and handling.

Keywords: HCV; Pakistan; hepatitis; plasma separation card; viral load.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Hepacivirus / genetics
  • Hepatitis C* / diagnosis
  • Humans
  • Plasma
  • RNA, Viral*
  • Sensitivity and Specificity
  • Viral Load / methods

Substances

  • RNA, Viral

Grants and funding